SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Doti AI raises $7M Seed round to help enterprises securely access and utilize internal data

Greylock appoints Mor Chen as partner to lead Israeli investments

Full list of Israeli high-tech funding rounds in 2025

Eleos doubles in value as it raises $60 million to disrupt behavioral healthcare

Buzz

Most popular

Daily

Weekly

1

Sam Altman-backed Apex Security in advanced talks to be acquired by Varonis for up to $40M

2

"Everyone will be a manager" - what the world of work will look like with AI agents

3

Facial recognition firm Oosto, formerly AnyVision, sold for $125M after raising $352M

4

What went wrong at AnyVision? Lessons from a $352M flameout

5

Mitiga raises $30M Series B to defend cloud services from cyberattacks

ALS

5 stories about ALS

NeuroSense & NeuraLight R&D Teams

NeuroSense Therapeutics and NeuraLight collaborate to detect ALS using AI

The collaboration between the Israeli companies will help the scientific community better understand Amyotrophic lateral sclerosis (ALS) and develop effective drugs to treat it

מוסף שבועי 10.9.20 ד"ר פיטר סקוט־מורגן

Mind over Matter: The man who turned himself into a cyborg to overcome ALS

13.09.20|Yoghev Carmel

After Peter Scott-Morgan was given a year to live, he decided to fight his fate and employed cutting edge technology to stay alive and remain human

תרופה תרופות סל התרופות

ALS Drug Developer NeuroSense Crowdfunds $1.15 Million

05.08.19|Adi Pick

The company’s 1,114 new investors will jointly own a 10% stake, the company said

Kadimastem Gets FDA Orphan Drug Designation for ALS Drug

04.11.18|Lilach Baumer

The biotech company is currently conducting an early clinical trial in Israel and expects results in mid-2019

חיים לייבוביץ' מנכ"ל בריינסטורם

Israeli ALS Treatment Developer Recruits Kite Pharma's CSO as Board Member

05.02.18|Dror Reich

Nasdaq-listed BrainStorm develops stem cell therapies for degenerative neurological diseases